- Home
- MBRX vs SRTAW Comparison
MBRX vs SRTAW Comparison
Compare MBRX & SRTAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBRX
- SRTAW
- Stock Information
- Founded
- MBRX 2015
- SRTAW N/A
- Country
- MBRX United States
- SRTAW United States
- Employees
- MBRX N/A
- SRTAW N/A
- Industry
- MBRX Biotechnology: Pharmaceutical Preparations
- SRTAW
- Sector
- MBRX Health Care
- SRTAW
- Exchange
- MBRX Nasdaq
- SRTAW Nasdaq
- Market Cap
- MBRX 17.1M
- SRTAW 16.3M
- IPO Year
- MBRX 2016
- SRTAW 2019
- Fundamental
- Price
- MBRX $0.38
- SRTAW $0.15
- Analyst Decision
- MBRX Strong Buy
- SRTAW
- Analyst Count
- MBRX 4
- SRTAW 0
- Target Price
- MBRX $5.00
- SRTAW N/A
- AVG Volume (30 Days)
- MBRX 4.0M
- SRTAW N/A
- Earning Date
- MBRX 11-07-2025
- SRTAW N/A
- Dividend Yield
- MBRX N/A
- SRTAW N/A
- EPS Growth
- MBRX N/A
- SRTAW N/A
- EPS
- MBRX N/A
- SRTAW N/A
- Revenue
- MBRX N/A
- SRTAW N/A
- Revenue This Year
- MBRX N/A
- SRTAW N/A
- Revenue Next Year
- MBRX N/A
- SRTAW N/A
- P/E Ratio
- MBRX N/A
- SRTAW N/A
- Revenue Growth
- MBRX N/A
- SRTAW N/A
- 52 Week Low
- MBRX $0.25
- SRTAW N/A
- 52 Week High
- MBRX $3.65
- SRTAW N/A
- Technical
- Relative Strength Index (RSI)
- MBRX 32.94
- SRTAW N/A
- Support Level
- MBRX $0.35
- SRTAW N/A
- Resistance Level
- MBRX $0.62
- SRTAW N/A
- Average True Range (ATR)
- MBRX 0.05
- SRTAW 0.00
- MACD
- MBRX -0.02
- SRTAW 0.00
- Stochastic Oscillator
- MBRX 8.19
- SRTAW 0.00
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.